Dermatology Research and Practice / 2014 / Article / Tab 2

Clinical Study

Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial

Table 2

Demographics and disease parameters of the 42 patients.

NB-UVBMinocycline

Number of patients2121
Age in years (mean ± SD)27.6 ± 9.425.4 ± 10.3
Sex (male/female)8/13 10/11
Duration of disease before commencing therapy in years (mean ± SD)15.13 ± 6.309.76 ± 3.84
Positive family history 2 4
Skin type
 Type 3 (%)16 (76.19%)18 (85.71%)
 Type 4 (%)5 (23.81%)3 (14.29%)
Mean body surface involved (mean ± SD)30.5 ± 10.535.5 ± 11.5
Anatomical
 Head and neck 912
 Trunk137
 Upper limb (proximal) 64
 Upper limb (distal) 86
 Lower limb (proximal) 56
 Lower limb (distal)43

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.